Conformation switch of NPC1 epitomizes a luminal alternating access for nonpolar substrates
摘要
Niemann-Pick disease type C (NPC) arises from failure of the NPC1 and/or NPC2 proteins to mobilize lysosomal cholesterol, yet the mechanism by which the complex drives sterol translocation lacks a thorough understanding (1, 2). Here, we capture an NPC1-NPC2 complex conformation at lysosomal pH using a bis-sterol ligand (JM046), fortifying NPC2 engagement with NPC1 and enabling structural characterization of an alternative transport state. In this complex, the sterol moiety is absent from the NPC1 central tunnel, and the neck site adopts an expanded architecture that resembles a previously observed NPC1 conformation at neutral pH, indicating that the tunnel geometry is not influenced by the pH alone. Instead, we provide evidence that cholesterol occupancy in the neck site is a key determinant of tunnel contraction. Supporting this notion, NPC1 purified from cholesterol-auxotrophic insect cells exhibits a similar expanded neck conformation. Integrating these structures and molecular dynamics (MD) simulations exploring the directional cholesterol handoff from NPC2 to the NPC1 tunnel, we propose a substrate-induced gating cycle where luminal and membrane-facing openings of NPC1 switch states in a coordinated manner to transfer cholesterol across the hydrophilic glycocalyx. This mechanism is reminiscent of the alternating access mechanism for hydrophobic substrate transfer. This framework synthesizes NPC1 conformational states into a mechanistic basis to classify pathogenic NPC variants by relevant transport steps, which will illuminate mechanism-guided therapeutic strategies.
参考文献
1. J. P. Davies, B. Levy, Y. A. Ioannou, Evidence for a Niemann–Pick C (NPC) Gene Family: Identification and Characterization of NPC1L1. Genomics 65, 137–145 (2000).
2. Y. A. Ioannou, Guilty until proven innocent: the case of NPC1 and cholesterol. Trends Biochem Sci 30, 498–505 (2005).
3. D. E. Sleat, et al., Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. P Natl Acad Sci Usa 101, 5886–5891 (2004).
4. K. Subramanian, W. E. Balch, NPC1/NPC2 function as a tag team duo to mobilize cholesterol. Proc National Acad Sci 105, 15223–15224 (2008).
5. P. G. Pentchev, et al., The Niemann-Pick C lesion and its relationship to the intracellular distribution and utilization of LDL cholesterol. Biochimica Et Biophysica Acta Bba - Mol Basis Dis 1225, 235–243 (1994).
6. E. D. Carstea, et al., Niemann-Pick C1 Disease Gene: Homology to Mediators of Cholesterol Homeostasis. Science 277, 228–231 (1997).
7. M. T. Vanier, Niemann-Pick disease type C. Orphanet J Rare Dis 5, 1–18 (2010).
8. T. Geberhiwot, et al., Consensus clinical management guidelines for Niemann-Pick disease type C. Orphanet J Rare Dis 13, 50 (2018).
9. M. C. Patterson, et al., Long‐term survival outcomes of patients with Niemann‐Pick disease type C receiving miglustat treatment: A large retrospective observational study. J Inherit Metab Dis 43, 1060–1069 (2020).
10. M. Vanier, G. Millat, Niemann–Pick disease type C. Clin Genet 64, 269–281 (2003).
11. M. C. Patterson, et al., Recommendations for the diagnosis and management of Niemann–Pick disease type C: An update. Mol Genet Metab 106, 330–344 (2012).
12. B. J. H. M. Poorthuis, et al., The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 105, 151–156 (1999).
13. M. Labrecque, L. Touma, C. Bhérer, A. Duquette, M. Tétreault, Estimated prevalence of Niemann–Pick type C disease in Quebec. Sci Rep-uk 11, 22621 (2021).
14. R. Pinto, et al., Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet 12, 87–92 (2004).
15. A. C. CROCKER, S. FARBER, NIEMANN-PICK DISEASE. Medicine 37, 1 (1958).
16. C. A. Wassif, et al., High incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets. Genet Med 18, 41 (2016).
17. F. M. Platt, G. R. Neises, R. A. Dwek, T. D. Butters, N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J Biological Chem 269, 8362–5 (1994).
18. M. C. Patterson, D. Vecchio, H. Prady, L. Abel, J. E. Wraith, Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurology 6, 765–772 (2007).
19. M. Pineda, M. Walterfang, M. C. Patterson, Miglustat in Niemann-Pick disease type C patients: a review. Orphanet J Rare Dis 13, 140 (2018).
20. M. L. Heras, et al., Understanding the phenotypic variability in Niemann-Pick disease type C (NPC): a need for precision medicine. npj Genom. Med. 8, 21 (2023).
21. F. D. Porter, et al., Cholesterol Oxidation Products Are Sensitive and Specific Blood-Based Biomarkers for Niemann-Pick C1 Disease. Sci Transl Med 2, 56ra81 (2010).
22. T. J. Maarup, et al., Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann–Pick C1. Mol Genet Metab 116, 75–79 (2015).
23. J. E. Megías-Vericat, et al., Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann–Pick type C disease: review of initial published cases. Neurol Sci 38, 727–743 (2017).
24. L. Abi-Mosleh, R. E. Infante, A. Radhakrishnan, J. L. Goldstein, M. S. Brown, Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells. Proc National Acad Sci 106, 19316–19321 (2009).
25. T.-Y. Chang, et al., Niemann-Pick Type C Disease and Intracellular Cholesterol Trafficking. Journal of Biological Chemistry 280, 20917–20920 (2005).
26. J. L. Goldstein, S. E. Dana, J. R. Faust, A. L. Beaudet, M. S. Brown, Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease. J Biological Chem 250, 8487–95 (1975).
27. J. P. Davies, Y. A. Ioannou, Topological analysis of NPC1 reveals that the orientation of the putative sterol sensing domain is identical to that of HMG CoA and SCAP. J Biol Chem 275, 24367–24374 (2000).
28. C. Scott, Y. A. Ioannou, The NPC1 protein: structure implies function. Biochimica Et Biophysica Acta Bba - Mol Cell Biology Lipids 1685, 8–13 (2004).
29. W. D. Park, et al., Identification of 58 novel mutations in Niemann‐Pick disease type C: Correlation with biochemical phenotype and importance of PTC1‐like domains in NPC1. Hum Mutat 22, 313–325 (2003).
30. E. Ikonen, Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Bio 9, 125–138 (2008).
31. K. Simons, E. Ikonen, How Cells Handle Cholesterol. Science 290, 1721–1726 (2000).
32. S. Naureckiene, et al., Identification of HE1 as the Second Gene of Niemann-Pick C Disease. Science 290, 2298–2301 (2000).
33. M. T. Vanier, G. Millat, Structure and function of the NPC2 protein. Biochimica Et Biophysica Acta Bba - Mol Cell Biology Lipids 1685, 14–21 (2004).
34. J. Storch, Z. Xu, Niemann–Pick C2 (NPC2) and intracellular cholesterol trafficking. Biochimica Et Biophysica Acta Bba - Mol Cell Biology Lipids 1791, 671–678 (2009).
35. M. S. Deffieu, S. R. Pfeffer, Niemann–Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding. Proc National Acad Sci 108, 18932–18936 (2011).
36. S. Xu, B. Benoff, H.-L. Liou, P. Lobel, A. M. Stock, Structural Basis of Sterol Binding by NPC2, a Lysosomal Protein Deficient in Niemann-Pick Type C2 Disease. J Biol Chem 282, 23525–23531 (2007).
37. R. E. Infante, et al., Purified NPC1 Protein I. BINDING OF CHOLESTEROL AND OXYSTEROLS TO A 1278-AMINO ACID MEMBRANE PROTEIN. J Biol Chem 283, 1052–1063 (2008).
38. R. E. Infante, et al., Purified NPC1 Protein II. LOCALIZATION OF STEROL BINDING TO A 240-AMINO ACID SOLUBLE LUMINAL LOOP. J Biol Chem 283, 1064–1075 (2008).
39. H. J. Kwon, et al., Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of Cholesterol. Cell 137, 1213–1224 (2009).
40. R. E. Infante, et al., NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes. Proc National Acad Sci 105, 15287–15292 (2008).
41. X. Li, P. Saha, J. Li, G. Blobel, S. R. Pfeffer, Clues to the mechanism of cholesterol transfer from the structure of NPC1 middle lumenal domain bound to NPC2. Proc National Acad Sci 113, 10079–10084 (2016).
42. H. Qian, et al., Structural Basis of Low-pH-Dependent Lysosomal Cholesterol Egress by NPC1 and NPC2. Cell 182, 98-111.e18 (2020).
43. M. L. Wang, et al., Identification of Surface Residues on Niemann-Pick C2 Essential for Hydrophobic Handoff of Cholesterol to NPC1 in Lysosomes. Cell Metab 12, 166–173 (2010).
44. N. Friedland, H.-L. Liou, P. Lobel, A. M. Stock, Structure of a cholesterol-binding protein deficient in Niemann–Pick type C2 disease. Proc National Acad Sci 100, 2512–2517 (2002).
45. X. Gong, et al., Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection. Cell 165, 1467–1478 (2016).
46. X. Li, et al., 3.3 Å structure of Niemann–Pick C1 protein reveals insights into the function of the C-terminal luminal domain in cholesterol transport. Proc National Acad Sci 114, 9116–9121 (2017).
47. X. Li, et al., Structure of human Niemann–Pick C1 protein. Proc National Acad Sci 113, 8212–8217 (2016).
48. V. Dubey, B. Bozorg, D. Wüstner, H. Khandelia, Cholesterol binding to the sterol-sensing region of Niemann Pick C1 protein confines dynamics of its N-terminal domain. Plos Comput Biol 16, e1007554 (2020).
49. C.-S. Huang, et al., Cryo-EM structures of NPC1L1 reveal mechanisms of cholesterol transport and ezetimibe inhibition. Sci Adv 6, eabb1989 (2020).
50. K. M. Frain, et al., Conformational changes in the Niemann–Pick type C1 protein NCR1 drive sterol translocation. Proc. Natl. Acad. Sci. 121, e2315575121 (2024).
51. T. Long, Y. Liu, Y. Qin, R. A. DeBose-Boyd, X. Li, Structures of dimeric human NPC1L1 provide insight into mechanisms for cholesterol absorption. Sci Adv 7, eabh3997 (2021).
52. J. C. Phillips, et al., Scalable molecular dynamics on CPU and GPU architectures with NAMD. J. Chem. Phys. 153, 044130 (2020).
53. J. C. Phillips, et al., Scalable molecular dynamics with NAMD. J. Comput. Chem. 26, 1781–802 (2005).
54. M. Silberkang, C. M. Havel, D. S. Friend, B. J. McCarthy, J. A. Watson, Isoprene synthesis in isolated embryonic Drosophila cells. I. Sterol-deficient eukaryotic cells. J. Biol. Chem. 258, 8503–8511 (1983).
55. G. Vinci, X. Xia, R. A. Veitia, Preservation of Genes Involved in Sterol Metabolism in Cholesterol Auxotrophs: Facts and Hypotheses. PLoS ONE 3, e2883 (2008).
56. K. Marheineke, S. Grünewald, W. Christie, H. Reiländer, Lipid composition of Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) insect cells used for baculovirus infection. FEBS Lett. 441, 49–52 (1998).
57. V. Cherezov, et al., High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor. Science 318, 1258–1265 (2007).
58. X. Wu, R. Yan, P. Cao, H. Qian, N. Yan, Structural advances in sterol-sensing domain-containing proteins. Trends Biochem Sci 47, 289–300 (2022).
59. E. Chovancova, et al., CAVER 3.0: A Tool for the Analysis of Transport Pathways in Dynamic Protein Structures. Plos Comput Biol 8, e1002708 (2012).
60. S. W. Altmann, et al., Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption. Science 303, 1201–1204 (2004).
61. D. S. Schade, L. Shey, R. P. Eaton, Cholesterol Review: A Metabolically Important Molecule. Endocr Pract 26, 1514–1523 (2020).
62. L. Ge, et al., Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake. Proc National Acad Sci 108, 551–556 (2011).
63. M. Hu, et al., Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake. Sci Adv 7, eabg3188 (2021).
64. K. Kazmier, D. P. Claxton, H. S. Mchaourab, Alternating access mechanisms of LeuT-fold transporters: trailblazing towards the promised energy landscapes. Curr Opin Struc Biol 45, 100–108 (2017).
65. D. Drew, R. A. North, K. Nagarathinam, M. Tanabe, Structures and General Transport Mechanisms by the Major Facilitator Superfamily (MFS). Chem. Rev. 121, 5289–5335 (2021).
66. Y. Shi, Common Folds and Transport Mechanisms of Secondary Active Transporters. Annu. Rev. Biophys. 42, 51–72 (2013).
67. W. F. Neiss, A coat of glycoconjugates on the inner surface of the lysosomal membrane in the rat kidney. Histochemistry 80, 603–608 (1984).
68. M. Kosicek, et al., N-glycome of the Lysosomal Glycocalyx is Altered in Niemann-Pick Type C Disease (NPC) Model Cells*. Mol. Cell. Proteom. 17, 631–642 (2018).
69. R. Liu, P. Lu, J. W. K. Chu, F. J. Sharom, Characterization of Fluorescent Sterol Binding to Purified Human NPC1. J Biol Chem 284, 1840–1852 (2009).
70. H. Nikaido, Y. Takatsuka, Mechanisms of RND multidrug efflux pumps. Biochimica Et Biophysica Acta Bba - Proteins Proteom 1794, 769–781 (2009).
71. L. Yu, W. Lu, Y. Wei, AcrB Trimer Stability and Efflux Activity, Insight from Mutagenesis Studies. Plos One 6, e28390 (2011).
72. M. C. Sulavik, et al., Antibiotic Susceptibility Profiles of Escherichia coli Strains Lacking Multidrug Efflux Pump Genes. Antimicrob Agents Ch 45, 1126–1136 (2001).
73. W. Lu, et al., Assembling of AcrB Trimer in Cell Membrane. J Mol Biol 423, 123–134 (2012).
74. H. I. Zgurskaya, H. Nikaido, Bypassing the periplasm: Reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. Proceedings of the National Academy of Sciences 96 (1999).
75. J. Kobylka, M. S. Kuth, R. T. Müller, E. R. Geertsma, K. M. Pos, AcrB: a mean, keen, drug efflux machine. Ann. N. York Acad. Sci. 1459, 38–68 (2020).
76. D. N. Mastronarde, SerialEM: A Program for Automated Tilt Series Acquisition on Tecnai Microscopes Using Prediction of Specimen Position. Microsc. Microanal. 9, 1182–1183 (2003).
77. D. Tegunov, P. Cramer, Real-time cryo-electron microscopy data preprocessing with Warp. Nat. Methods 16, 1146–1152 (2019).
78. S. H. W. Scheres, RELION: Implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol 180, 519–530 (2012).
79. X. Yao, X. Fan, N. Yan, Cryo-EM analysis of a membrane protein embedded in the liposome. Proc. Natl. Acad. Sci. 117, 18497–18503 (2020).
80. P. B. Rosenthal, R. Henderson, Optimal Determination of Particle Orientation, Absolute Hand, and Contrast Loss in Single-particle Electron Cryomicroscopy. J Mol Biol 333, 721–745 (2003).
81. A. Punjani, J. L. Rubinstein, D. J. Fleet, M. A. Brubaker, cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods 14, 290–296 (2017).
82. A. Punjani, H. Zhang, D. J. Fleet, Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214–1221 (2020).
83. A. Punjani, D. J. Fleet, 3D variability analysis: Resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM. J Struct Biol 213, 107702 (2021).
84. E. F. Pettersen, et al., UCSF Chimera—A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
85. P. Emsley, B. Lohkamp, W. G. Scott, K. Cowtan, Features and development of Coot. Acta Crystallogr Sect D 66, 486–501 (2010).
86. P. D. Adams, et al., PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr Sect D Biological Crystallogr 66, 213–221 (2010).
87. W. Humphrey, A. Dalke, K. Schulten, VMD: Visual molecular dynamics. J. Mol. Graph. 14, 33–38 (1996).
88. M. H. M. Olsson, C. R. Søndergaard, M. Rostkowski, J. H. Jensen, PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. J. Chem. theory Comput. 7, 525–37 (2011).
89. M. A. Lomize, A. L. Lomize, I. D. Pogozheva, H. I. Mosberg, OPM: Orientations of Proteins in Membranes database. Bioinformatics 22, 623–625 (2006).
90. G. Licari, S. Dehghani-Ghahnaviyeh, E. Tajkhorshid, Membrane Mixer: A Toolkit for Efficient Shuffling of Lipids in Heterogeneous Biological Membranes. J. Chem. Inf. Model. 62, 986–996 (2022).
91. J. B. Klauda, et al., Update of the CHARMM All-Atom Additive Force Field for Lipids: Validation on Six Lipid Types. J. Phys. Chem. B 114, 7830–7843 (2010).
92. W. L. Jorgensen, J. Chandrasekhar, J. D. Madura, R. W. Impey, M. L. Klein, Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926–935 (1983).
93. T. Darden, D. York, L. Pedersen, Particle mesh Ewald: An N ⋅log( N ) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089–10092 (1993).
94. J.-P. Ryckaert, G. Ciccotti, H. J. C. Berendsen, Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327–341 (1977).
95. G. J. Martyna, D. J. Tobias, M. L. Klein, Constant pressure molecular dynamics algorithms. J. Chem. Phys. 101, 4177–4189 (1994).
96. S. E. Feller, Y. Zhang, R. W. Pastor, B. R. Brooks, Constant pressure molecular dynamics simulation: The Langevin piston method. J. Chem. Phys. 103, 4613–4621 (1995).
97. S. J. Marrink, H. J. Risselada, S. Yefimov, D. P. Tieleman, A. H. de Vries, The MARTINI Force Field: Coarse Grained Model for Biomolecular Simulations. J. Phys. Chem. B 111, 7812–7824 (2007).
98. D. H. de Jong, et al., Improved Parameters for the Martini Coarse-Grained Protein Force Field. J. Chem. Theory Comput. 9, 687–697 (2013).
99. M. J. Abraham, et al., GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1, 19–25 (2015).
指标
DOI:
Submission ID:
下载次数
附加文件
补充文件
已发布
如何引用
下载引用
利益冲突声明
作者声明无任何需要披露的利益冲突。
Copyright
本预印本的版权持有者为作者/资助方。

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.